祖细胞
生物
造血
细胞生物学
干细胞
T细胞受体
细胞分化
T细胞
免疫学
分子生物学
免疫系统
遗传学
基因
作者
Christopher S. Seet,Chongbin He,Michael T. Bethune,Suwen Li,Brent Chick,Eric H. Gschweng,Yuhua Zhu,Kenneth Kim,Donald B. Kohn,David Baltimore,Gay M. Crooks,Amélie Montel‐Hagen
出处
期刊:Nature Methods
[Nature Portfolio]
日期:2017-04-03
卷期号:14 (5): 521-530
被引量:211
摘要
This paper describes an in vitro method to generate human T cells from hematopoietic stem and progenitor cells (HSPCs). It should be useful for both basic and applied studies using T cells. Studies of human T cell development require robust model systems that recapitulate the full span of thymopoiesis, from hematopoietic stem and progenitor cells (HSPCs) through to mature T cells. Existing in vitro models induce T cell commitment from human HSPCs; however, differentiation into mature CD3+TCR-αβ+ single-positive CD8+ or CD4+ cells is limited. We describe here a serum-free, artificial thymic organoid (ATO) system that supports efficient and reproducible in vitro differentiation and positive selection of conventional human T cells from all sources of HSPCs. ATO-derived T cells exhibited mature naive phenotypes, a diverse T cell receptor (TCR) repertoire and TCR-dependent function. ATOs initiated with TCR-engineered HSPCs produced T cells with antigen-specific cytotoxicity and near-complete lack of endogenous TCR Vβ expression, consistent with allelic exclusion of Vβ-encoding loci. ATOs provide a robust tool for studying human T cell differentiation and for the future development of stem-cell-based engineered T cell therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI